Table 1 Reasons for delay or discontinuationin patients who received gemcitabine systemic chemotherapy
From: Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy
No. of patients (%) | ||
|---|---|---|
Non-hematological, n (%) | Treatment delay, n = 94a | Discontinuation of gemcitabine, n = 6 |
Vomiting | 5 (5.3) | 0 |
Infection | 10 (10.6) | 0 |
Drug-induced pneumonia | 0 | 2 (33.3) |
Diarrhea | 2 (2.1) | 0 |
Malaise | 4 (4.3) | 1 (16.7) |
Patient’s wish | 3 (3.2) | 0 |
Hematological, n (%) | ||
Neutrophil count decreased | 36 (38.3) | 0 |
Anemia | 7 (7.4) | 1 (16.7) |
Platelet count decreased | 15 (16.0) | 1 (16.7) |
AST or ALT increased | 4 (4.3) | 0 |
Blood bilirubin increased | 5 (5.3) | 1 (16.7) |
Creatinine increased | 1 (1.1) | 0 |
Hypoalbuminemia | 2 (2.1) | 0 |